Effects of psyllium on metabolic syndrome risk factors

Obesity Reviews

Volumn 13, Issue 11, 2012, Pages 1034-1047

  Pal, Sebely ^a   Radavelli Bagatini, Simone ^a  

^a CURTIN UNIVERSITY   (Australia)

Author keywords

Dietary fibre; Metabolic syndrome; Obesity; Psyllium fibre.

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B48; CARBOHYDRATE; CHOLESTEROL; FATTY ACID; GHRELIN; GLUCOSE; GLUCOSE TRANSPORTER 4; GUAR GUM; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; INSULIN; ISPAGULA; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PEPTIDE YY; TRIACYLGLYCEROL;

APPETITE; ARTICLE; BLOOD PRESSURE REGULATION; BODY COMPOSITION; BODY MASS; BODY WEIGHT; CARDIOVASCULAR RISK; DIASTOLIC BLOOD PRESSURE; DIET SUPPLEMENTATION; DIETARY FIBER; DRUG EFFECT; GLUCOSE BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PHYSICAL ACTIVITY; PROTEIN EXPRESSION; STOMACH EMPTYING; SYSTOLIC BLOOD PRESSURE; WEIGHT REDUCTION; WHEAT BRAN;

ANIMALS; APPETITE; BLOOD GLUCOSE; DIETARY FIBER; DIETARY SUPPLEMENTS; HUMANS; METABOLIC SYNDROME X; PSYLLIUM; RISK FACTORS;

EID: 84867895281     PISSN: 14677881     EISSN: 1467789X     Source Type: Journal    
DOI: 10.1111/j.1467-789X.2012.01020.x     Document Type: Article

References (116)

1. Mokdad AH, Ford ES, Bowman BA etal. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003; 289: 76-79.
2. WHO. Nutrition: Controlling the Global Obesity Epidemic. World Health Organization: Geneva, 2002.
3. WHO. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000; 894: i-xii, 1-253.
4. Wilborn C, Beckham J, Campbell B etal. Obesity: prevalence, theories, medical consequences, management, and research directions. J Int Soc Sports Nutr 2005; 2: 4-31.
5. Cook S, Hugli O, Egli M etal. Clustering of cardiovascular risk factors mimicking the human metabolic syndrome X in eNOS null mice. Swiss Med Wkly 2003; 133: 360-363.
6. Isomaa B, Almgren P, Tuomi T etal. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683-689.
7. Grundy SM. Obesity, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab 2004; 89: 2595-2600.
8. Kones R. Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey. Drug Des Devel Ther 2011; 5: 325-380.
9. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome-a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 2006; 23: 469-480.
10. Du H, van der AD, Boshuizen HC etal. Dietary fiber and subsequent changes in body weight and waist circumference in European men and women. Am J Clin Nutr 2010; 91: 329-336.
11. Newby PK, Maras J, Bakun P, Muller D, Ferrucci L, Tucker KL. Intake of whole grains, refined grains, and cereal fiber measured with 7-d diet records and associations with risk factors for chronic disease. Am J Clin Nutr 2007; 86: 1745-1753.
12. NHMRC. Dietary guidelines for Australian adults. National Health and Medical Research Council; Canberra: Commonwealth of Australia, 2003.
13. Wu H, Dwyer KM, Fan Z, Shircore A, Fan J, Dwyer JH. Dietary fiber and progression of atherosclerosis: the Los Angeles Atherosclerosis Study. Am J Clin Nutr 2003; 78: 1085-1091.
14. Lairon D. Macronutrient intake and modulation on chylomicron production and clearance. Atheroscler Suppl 2008; 9: 45-48.
15. Kan H, Stevens J, Heiss G, Klein R, Rose KM, London SJ. Dietary fiber intake and retinal vascular caliber in the Atherosclerosis Risk in Communities Study. Am J Clin Nutr 2007; 86: 1626-1632.
16. Lairon D, Arnault N, Bertrais S etal. Dietary fiber intake and risk factors for cardiovascular disease in French adults. Am J Clin Nutr 2005; 82: 1185-1194.
17. Venn BJ, Mann JI. Cereal grains, legumes and diabetes. Eur J Clin Nutr 2004; 58: 1443-1461.
18. Weickert MO, Pfeiffer AF. Metabolic effects of dietary fiber consumption and prevention of diabetes. J Nutr 2008; 138: 439-442.
19. McKeown NM, Meigs JB, Liu S, Wilson PW, Jacques PF. Whole-grain intake is favorably associated with metabolic risk factors for type 2 diabetes and cardiovascular disease in the Framingham Offspring Study. Am J Clin Nutr 2002; 76: 390-398.
20. Brown L, Rosner B, Willett WW, Sacks FM. Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr 1999; 69: 30-42.
21. Pittler MH, Ernst E. Guar gum for body weight reduction: meta-analysis of randomized trials. Am J Med 2001; 110: 724-730.
22. Ludwig DS, Pereira MA, Kroenke CH etal. Dietary fiber, weight gain, and cardiovascular disease risk factors in young adults. JAMA 1999; 282: 1539-1546.
23. Marlett JA, McBurney MI, Slavin JL. Position of the American Dietetic Association: health implications of dietary fiber. J Am Diet Assoc 2002; 102: 993-1000.
24. Alaimo K, McDowell MA, Briefel RR etal. Dietary intake of vitamins, minerals, and fiber of persons ages 2 months and over in the United States: Third National Health and Nutrition Examination Survey, Phase 1, 1988-91. Adv Data 1994; 14: 1-28.
25. CSFII. Continuing Survey of Food Intakes by Individuals (CSFII) 1994-96, 98. Agricultural Research Services, US Department of Agriculture: Washington, DC, 2000.
26. IOM. Dietary, functional, and total fiber. In: The National Academies Press (ed.). DRI: Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids. Food and Nutrition Board: Washington, DC, 2005, pp. 339-421.
27. Blackwood AD, Salter J, Dettmar PW, Chaplin MF. Dietary fibre, physicochemical properties and their relationship to health. J R Soc Promot Health 2000; 120: 242-247.
28. Galisteo M, Sanchez M, Vera R etal. A diet supplemented with husks of plantago ovata reduces the development of endothelial dysfunction, hypertension, and obesity by affecting adiponectin and TNF-{alpha} in obese zucker rats. J Nutr 2005; 135: 2399-2404.
29. Obata K, Ikeda K, Yamasaki M, Yamori Y. Dietary fiber, psyllium, attenuates salt-accelerated hypertension in stroke-prone spontaneously hypertensive rats. J Hypertens 1998; 16: 1959-1964.
30. Song YJ, Sawamura M, Ikeda K, Igawa S, Yamori Y. Soluble dietary fibre improves insulin sensitivity by increasing muscle GLUT-4 content in stroke-prone spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 2000; 27: 41-45.
31. Anderson JW, Zettwoch N, Feldman T, Tietyen-Clark J, Oeltgen P, Bishop CW. Cholesterol-lowering effects of psyllium hydrophilic mucilloid for hypercholesterolemic men. Arch Intern Med 1988; 148: 292-296.
32. Burke V, Hodgson JM, Beilin LJ, Giangiulioi N, Rogers P, Puddey IB. Dietary protein and soluble fiber reduce ambulatory blood pressure in treated hypertensives. Hypertension 2001; 38: 821-826.
33. Cicero AF, Derosa G, Manca M, Bove M, Borghi C, Gaddi AV. Different effect of psyllium and guar dietary supplementation on blood pressure control in hypertensive overweight patients: a six-month, randomized clinical trial. Clin Exp Hypertens 2007; 29: 383-394.
34. Khossousi A, Binns CW, Dhaliwal SS, Pal S. The acute effects of psyllium on postprandial lipaemia and thermogenesis in overweight and obese men. Br J Nutr 2008; 99: 1068-1075.
35. Pal S, Khossousi A, Binns C, Dhaliwal S, Ellis V. The effect of a fibre supplement compared to a healthy diet on body composition, lipids, glucose, insulin and other metabolic syndrome risk factors in overweight and obese individuals. Br J Nutr 2011; 105: 90-100.
36. Ziai SA, Larijani B, Akhoondzadeh S etal. Psyllium decreased serum glucose and glycosylated hemoglobin significantly in diabetic outpatients. J Ethnopharmacol 2005; 102: 202-207.
37. National Health and Medical Research Council. Nutrient Reference Values for Australia and New Zealand. Council NHaMRC: Canberra, 2005.
38. Mittendorfer B, Patterson BW, Klein S, Sidossis LS. VLDL-triglyceride kinetics during hyperglycemia-hyperinsulinemia: effects of sex and obesity. Am J Physiol Endocrinol Metab 2003; 284: E708-E715.
39. Anderson JW, Allgood LD, Lawrence A etal. Cholesterol-lowering effects of psyllium intake adjunctive to diet therapy in men and women with hypercholesterolemia: meta-analysis of 8 controlled trials. Am J Clin Nutr 2000; 71: 472-479.
40. Cummings JH. Fermentation in the human large intestine: evidence and implications for health. Lancet 1983; 1: 1206-1209.
41. Marlett JA, Fischer MH. A poorly fermented gel from psyllium seed husk increases excreta moisture and bile acid excretion in rats. J Nutr 2002; 132: 2638-2643.
42. Marlett JA, Fischer MH. The active fraction of psyllium seed husk. Proc Nutr Soc 2003; 62: 207-209.
43. Marlett JA, Kajs TM, Fischer MH. An unfermented gel component of psyllium seed husk promotes laxation as a lubricant in humans. Am J Clin Nutr 2000; 72: 784-789.
44. Karhunen LJ, Juvonen KR, Flander SM etal. A psyllium fiber-enriched meal strongly attenuates postprandial gastrointestinal peptide release in healthy young adults. J Nutr 2010; 140: 737-744.
45. Sierra M, Garcia JJ, Fernandez N, Diez MJ, Calle AP. Therapeutic effects of psyllium in type 2 diabetic patients. Eur J Clin Nutr 2002; 56: 830-842.
46. Moreno LA, Tresaco B, Bueno G etal. Psyllium fibre and the metabolic control of obese children and adolescents. J Physiol Biochem 2003; 59: 235-242.
47. Gropper SS, Acosta PB. The therapeutic effect of fiber in treating obesity. J Am Coll Nutr 1987; 6: 533-535.
48. Dunaif G, Schneeman BO. The effect of dietary fiber on human pancreatic enzyme activity in vitro. Am J Clin Nutr 1981; 34: 1034-1035.
49. Anderson JW, Riddell-Mason S, Gustafson NJ, Smith SF, Mackey M. Cholesterol-lowering effects of psyllium-enriched cereal as an adjunct to a prudent diet in the treatment of mild to moderate hypercholesterolemia. Am J Clin Nutr 1992; 56: 93-98.
50. Levrat MA, Favier ML, Moundras C, Remesy C, Demigne C, Morand C. Role of dietary propionic acid and bile acid excretion in the hypocholesterolemic effects of oligosaccharides in rats. J Nutr 1994; 124: 531-538.
51. Rodriguez-Moran M, Guerrero-Romero F, Lazcano-Burciaga G. Lipid- and glucose-lowering efficacy of Plantago Psyllium in type II diabetes. J Diabetes Complications 1998; 12: 273-278.
52. Tai ES, Fok AC, Chu R, Tan CE. A study to assess the effect of dietary supplementation with soluble fibre (Minolest) on lipid levels in normal subjects with hypercholesterolaemia. Ann Acad Med Singapore 1999; 28: 209-213.
53. Vuksan V, Jenkins AL, Rogovik AL, Fairgrieve CD, Jovanovski E, Leiter LA. Viscosity rather than quantity of dietary fibre predicts cholesterol-lowering effect in healthy individuals. Br J Nutr 2011; 106: 1349-1352.
54. Wanders AJ, van den Borne JJ, de Graaf C etal. Effects of dietary fibre on subjective appetite, energy intake and body weight: a systematic review of randomized controlled trials. Obes Rev 2011; 12: 724-739.
55. Turnbull WH, Thomas HG. The effect of a Plantago ovata seed containing preparation on appetite variables, nutrient and energy intake. Int J Obes Relat Metab Disord 1995; 19: 338-342.
56. Jequier E. Pathways to obesity. Int J Obes Relat Metab Disord 2002; 26(Suppl. 2): S12-S17.
57. Paddon-Jones D, Westman E, Mattes RD, Wolfe RR, Astrup A, Westerterp-Plantenga M. Protein, weight management, and satiety. Am J Clin Nutr 2008; 87: 1558S-1561S.
58. Anderson GH, Moore SE. Dietary proteins in the regulation of food intake and body weight in humans. J Nutr 2004; 134: 974S-979S.
59. Weigle DS, Breen PA, Matthys CC etal. A high-protein diet induces sustained reductions in appetite, ad libitum caloric intake, and body weight despite compensatory changes in diurnal plasma leptin and ghrelin concentrations. Am J Clin Nutr 2005; 82: 41-48.
60. Delargy HJ, O'Sullivan KR, Fletcher RJ, Blundell JE. Effects of amount and type of dietary fibre (soluble and insoluble) on short-term control of appetite. Int J Food Sci Nutr 1997; 48: 67-77.
61. Yao M, Roberts SB. Dietary energy density and weight regulation. Nutr Rev 2001; 59: 247-258.
62. Holt S, Brand J, Soveny C, Hansky J. Relationship of satiety to postprandial glycaemic, insulin and cholecystokinin responses. Appetite 1992; 18: 129-141.
63. Burton-Freeman B, Davis PA, Schneeman BO. Plasma cholecystokinin is associated with subjective measures of satiety in women. Am J Clin Nutr 2002; 76: 659-667.
64. Anderson JW, Randles KM, Kendall CWC, Jenkins DJA. Carbohydrate and fiber recommendations for individuals with diabetes: a quantitative assessment and meta-analysis of the evidence. J Am Coll Nutr 2004; 23: 5-17.
65. Pereira MA, Ludwig DS. Dietary fiber and body-weight regulation. Observations and mechanisms. Pediatr Clin North Am 2001; 48: 969-980.
66. Zijlstra N, de Wijk RA, Mars M, Stafleu A, de Graaf C. Effect of bite size and oral processing time of a semisolid food on satiation. Am J Clin Nutr 2009; 90: 269-275.
67. Zijlstra N, Mars M, de Wijk RA, Westerterp-Plantenga MS, de Graaf C. The effect of viscosity on ad libitum food intake. Int J Obes (Lond) 2008; 32: 676-683.
68. Drewnowski A. Energy density, palatability, and satiety: implications for weight control. Nutr Rev 1998; 56: 347-353.
69. Dikeman CL, Murphy MR, Fahey GC Jr. Dietary fibers affect viscosity of solutions and simulated human gastric and small intestinal digesta. J Nutr 2006; 136: 913-919.
70. Baer DJ, Rumpler WV, Miles CW, Fahey GC Jr. Dietary fiber decreases the metabolizable energy content and nutrient digestibility of mixed diets fed to humans. J Nutr 1997; 127: 579-586.
71. Sleeth ML, Thompson EL, Ford HE, Zac-Varghese SE, Frost G. Free fatty acid receptor 2 and nutrient sensing: a proposed role for fibre, fermentable carbohydrates and short-chain fatty acids in appetite regulation. Nutr Res Rev 2010; 23: 135-145.
72. FDA. Control of health claims in foods. Lancet 1998; 351: 609.
73. Jenkins DJ, Kendall CW, Vuksan V etal. Soluble fiber intake at a dose approved by the US Food and Drug Administration for a claim of health benefits: serum lipid risk factors for cardiovascular disease assessed in a randomized controlled crossover trial. Am J Clin Nutr 2002; 75: 834-839.
74. Olson BH, Anderson SM, Becker MP etal. Psyllium-enriched cereals lower blood total cholesterol and LDL cholesterol, but not HDL cholesterol, in hypercholesterolemic adults: results of a meta-analysis. J Nutr 1997; 127: 1973-1980.
75. Cornfine C, Hasenkopf K, Eisner P, Schweiggert U. Influence of chemical and physical modification on the bile acid binding capacity of dietary fibre from lupins (Lupinus angustifolius L.). Food Chem 2010; 122: 638-644.
76. Anderson JW, Allgood LD, Turner J, Oeltgen PR, Daggy BP. Effects of psyllium on glucose and serum lipid responses in men with type 2 diabetes and hypercholesterolemia. Am J Clin Nutr 1999; 70: 466-473.
77. Ellegard L, Andersson H. Oat bran rapidly increases bile acid excretion and bile acid synthesis: an ileostomy study. Eur J Clin Nutr 2007; 61: 938-945.
78. Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science 1986; 232: 34-47.
79. Gunness P, Gidley MJ. Mechanisms underlying the cholesterol-lowering properties of soluble dietary fibre polysaccharides. Food Funct 2010; 1: 149-155.
80. Lairon D, Play B, Jourdheuil-Rahmani D. Digestible and indigestible carbohydrates: interactions with postprandial lipid metabolism. J Nutr Biochem 2007; 18: 217-227.
81. Bourdon I, Yokoyama W, Davis P etal. Postprandial lipid, glucose, insulin, and cholecystokinin responses in men fed barley pasta enriched with beta-glucan. Am J Clin Nutr 1999; 69: 55-63.
82. Potter JG, Coffman KP, Reid RL, Krall JM, Albrink MJ. Effect of test meals of varying dietary fiber content on plasma insulin and glucose response. Am J Clin Nutr 1981; 34: 328-334.
83. Lundin EA, Zhang JX, Lairon D etal. Effects of meal frequency and high-fibre rye-bread diet on glucose and lipid metabolism and ileal excretion of energy and sterols in ileostomy subjects. Eur J Clin Nutr 2004; 58: 1410-1419.
84. Anderson JW, Davidson MH, Blonde L etal. Long-term cholesterol-lowering effects of psyllium as an adjunct to diet therapy in the treatment of hypercholesterolemia. Am J Clin Nutr 2000; 71: 1433-1438.
85. WHO. Diet, Nutrition and the Prevention of Chronic Diseases. World Health Organization and FAO: Geneva, 2003.
86. Li J, Wang J, Kaneko T, Qin LQ, Sato A. Effects of fiber intake on the blood pressure, lipids, and heart rate in Goto Kakizaki rats. Nutrition 2004; 20: 1003-1007.
87. Pal S, Khossousi A, Binns C, Dhaliwal S, Radavelli-Bagatini S. The effects of 12-week psyllium fibre supplementation or healthy diet on blood pressure and arterial stiffness in overweight and obese individuals. Br J Nutr 2012; 107: 725-734.
88. Ferrara LA, Guida L, Iannuzzi R, Celentano A, Lionello F. Serum cholesterol affects blood pressure regulation. J Hum Hypertens 2002; 16: 337-343.
89. Creager MA, Cooke JP, Mendelsohn ME etal. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest 1990; 86: 228-234.
90. Laurenzi M, Mancini M, Menotti A etal. Multiple risk factors in hypertension: results from the Gubbio study. J Hypertens Suppl 1990; 8: S7-12.
91. Hayakawa H, Raij L. Relationship between hypercholesterolaemia, endothelial dysfunction and hypertension. J Hypertens 1999; 17: 611-619.
92. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 1989; 2: 997-1000.
93. Anderson JW, Zeigler JA, Deakins DA etal. Metabolic effects of high-carbohydrate, high-fiber diets for insulin-dependent diabetic individuals. Am J Clin Nutr 1991; 54: 936-943.
94. Fukagawa NK, Anderson JW, Hageman G, Young VR, Minaker KL. High-carbohydrate, high-fiber diets increase peripheral insulin sensitivity in healthy young and old adults. Am J Clin Nutr 1990; 52: 524-528.
95. Ferrannini E, Buzzigoli G, Bonadonna R etal. Insulin resistance in essential hypertension. N Engl J Med 1987; 317: 350-357.
96. Bessesen D. The role of carbohydrates in insulin resistance. J Nutr 2001; 131: 2782S-2786S.
97. Ferrannini E, Haffner SM, Mitchell BD, Stern MP. Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 1991; 34: 416-422.
98. King DE, Mainous AG, Egan BM, Woolson RF, Geesey ME. Fiber and C-reactive protein in diabetes, hypertension, and obesity. Diabetes Care 2005; 28: 1487-1489.
99. Qi L, Rimm E, Liu S, Rifai N, Hu FB. Dietary glycemic index, glycemic load, cereal fiber, and plasma adiponectin concentration in diabetic men. Diabetes Care 2005; 28: 1022-1028.
100. Wilkinson IB, Prasad K, Hall IR etal. Increased central pulse pressure and augmentation index in subjects with hypercholesterolemia. J Am Coll Cardiol 2002; 39: 1005-1011.
101. Blacher J, Safar ME. Large-artery stiffness, hypertension and cardiovascular risk in older patients. Nat Clin Pract 2005; 2: 450-455.
102. Safar ME. Systolic blood pressure, pulse pressure and arterial stiffness as cardiovascular risk factors. Curr Opin Nephrol Hypertens 2001; 10: 257-261.
103. Tomiyama H, Hashimoto H, Hirayama Y etal. Synergistic acceleration of arterial stiffening in the presence of raised blood pressure and raised plasma glucose. Hypertension 2006; 47: 180-188.
104. Qureshi G, Brown R, Salciccioli L etal. Relationship between aortic atherosclerosis and non-invasive measures of arterial stiffness. Atherosclerosis 2007; 195: e190-e194.
105. Casey DP, Pierce GL, Howe KS, Mering MC, Braith RW. Effect of resistance training on arterial wave reflection and brachial artery reactivity in normotensive postmenopausal women. Eur J Appl Physiol 2007; 100: 403-408.
106. Greenwald SE. Ageing of the conduit arteries. J Pathol 2007; 211: 157-172.
107. McEniery CM, Cockcroft JR. Does arterial stiffness predict atherosclerotic coronary events? Adv Cardiol 2007; 44: 160-172.
108. Safar ME, Thomas F, Blacher J etal. Metabolic syndrome and age-related progression of aortic stiffness. J Am Coll Cardiol 2006; 47: 72-75.
109. Ostmark E, Harrisson S, Wooley KL, Malmstrom EE. Comb polymers prepared by ATRP from hydroxypropyl cellulose. Biomacromolecules 2007; 8: 1138-1148.
110. Izzo JL Jr, Shykoff BE. Arterial stiffness: clinical relevance, measurement, and treatment. Rev Cardiovasc Med 2001; 2: 29-34, 37-40.
111. Scuteri A, Najjar SS, Muller DC etal. Metabolic syndrome amplifies the age-associated increases in vascular thickness and stiffness. J Am Coll Cardiol 2004; 43: 1388-1395.
112. Arnett DK, Tyroler HA, Burke G, Hutchinson R, Howard G, Heiss G. Hypertension and subclinical carotid artery atherosclerosis in blacks and whites. Arch Intern Med 1996; 156: 1983-1989.
113. Amar J, Ruidavets JB, Chamontin B, Drouet L, Ferrieres J. Arterial stiffness and cardiovascular risk factors in a population-based study. J Hypertens 2001; 19: 381-387.
114. Benetos A, Waeber B, Izzo J etal. Influence of age, risk factors, and cardiovascular and renal disease on arterial stiffness: clinical applications. Am J Hypertens 2002; 15: 1101-1108.
115. Seals DR, Moreau KL, Gates PE, Eskurza I. Modulatory influences on ageing of the vasculature in healthy humans. Exp Gerontol 2006; 41: 501-507.
116. Wilkinson IB, Qasem A, McEniery CM, Webb DJ, Avolio AP, Cockcroft JR. Nitric oxide regulates local arterial distensibility in vivo. Circulation 2002; 105: 213-217.